Lin, C., Anderson, C. E., Scobie, M. R., Rodgers, T. D., Kelley, M. J., & Friedman, D. R. (2024). Outcomes of Bruton tyrosine kinase inhibitors for chronic lymphocytic leukaemia in US veterans with severe renal dysfunction. Br J Haematol. https://doi.org/10.1111/bjh.19737

Lin, Chenyu, Clare E. Anderson, Micaela R. Scobie, Thomas D. Rodgers, Michael J. Kelley, and Daphne R. Friedman. “Outcomes of Bruton tyrosine kinase inhibitors for chronic lymphocytic leukaemia in US veterans with severe renal dysfunction.” Br J Haematol, August 29, 2024. https://doi.org/10.1111/bjh.19737.

Lin C, Anderson CE, Scobie MR, Rodgers TD, Kelley MJ, Friedman DR. Outcomes of Bruton tyrosine kinase inhibitors for chronic lymphocytic leukaemia in US veterans with severe renal dysfunction. Br J Haematol. 2024 Aug 29;

Lin, Chenyu, et al. “Outcomes of Bruton tyrosine kinase inhibitors for chronic lymphocytic leukaemia in US veterans with severe renal dysfunction.” Br J Haematol, Aug. 2024. Pubmed, doi:10.1111/bjh.19737.

Lin C, Anderson CE, Scobie MR, Rodgers TD, Kelley MJ, Friedman DR. Outcomes of Bruton tyrosine kinase inhibitors for chronic lymphocytic leukaemia in US veterans with severe renal dysfunction. Br J Haematol. 2024 Aug 29;